{
  "abstract": "Immune-mediated inflammatory diseases (IMIDs) are a group of pathologies characterised by acute or chronic inflammation that can affect a multitude of organs such as the skin, joints or digestive tract.1 Their prevalence in Western society is between 5% and 7%.2",
  "authors": [
    {
      "affiliations": [
        "Pharmacy, SERGAS, Santiago de Compostela, A Coruña, Spain"
      ],
      "name": "Aron Misa Garcia"
    },
    {
      "affiliations": [
        "Pharmacy, SERGAS, Santiago de Compostela, A Coruña, Spain"
      ],
      "name": "Sara Ferro Rodríguez"
    }
  ],
  "title": "Optimising adalimumab administration to improve patient experience and treatment adherence in immune-mediated inflammatory diseases",
  "uid": "e31240e7-3f73-5b61-bd4d-bdf5df3d330c"
}